Periciazine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01608 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 58 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | atrophoderma vermiculata | KG + DL |
| 4 | dysthymic disorder | KG + DL |
| 5 | migraine with or without aura, susceptibility to | KG + DL |
| 6 | ulerythema ophryogenesis | KG + DL |
| 7 | sciatic neuropathy | KG + DL |
| 8 | anxiety | KG + DL |
| 9 | anxiety disorder | KG + DL |
| 10 | open-angle glaucoma | KG + DL |
| 11 | primary hereditary glaucoma | KG + DL |
| 12 | congenital hypotrichosis milia | KG + DL |
| 13 | diffuse alopecia areata | KG + DL |
| 14 | Tourette syndrome | KG + DL |
| 15 | hypotrichosis simplex of the scalp | KG + DL |
| 16 | trichotillomania | KG + DL |
| 17 | alopecia | KG + DL |
| 18 | headache disorder | KG + DL |
| 19 | benign paroxysmal torticollis of infancy | KG + DL |
| 20 | restless legs syndrome | KG + DL |
| 21 | neurotic disorder | KG + DL |
| 22 | agoraphobia | KG + DL |
| 23 | cauda equina syndrome | KG + DL |
| 24 | manic bipolar affective disorder | KG + DL |
| 25 | Keppen-Lubinsky syndrome | KG + DL |
| 26 | trigeminal autonomic cephalalgia | KG + DL |
| 27 | attention deficit-hyperactivity disorder | KG + DL |
| 28 | autosomal dominant slowed nerve conduction velocity | KG + DL |
| 29 | neurotic depression | KG + DL |
| 30 | melancholia | KG + DL |
| 31 | vitamin B12-responsive methylmalonic acidemia | KG + DL |
| 32 | Ohdo syndrome and variants | KG + DL |
| 33 | congenital isolated adrenocorticotropic hormone deficiency (disease) | KG + DL |
| 34 | postural orthostatic tachycardia syndrome | KG + DL |
| 35 | faciodigitogenital syndrome | KG + DL |
| 36 | tendinitis | KG + DL |
| 37 | obsolete neurogenic bladder (disease) | KG + DL |
| 38 | fibromyalgia | KG + DL |
| 39 | blepharophimosis - intellectual disability syndrome, Ohdo type | KG + DL |
| 40 | myositis fibrosa | KG + DL |
| 41 | idiopathic granulomatous myositis | KG + DL |
| 42 | peripheral motor neuropathy-dysautonomia syndrome | KG + DL |
| 43 | chondromyxoid fibroma | KG + DL |
| 44 | multiple system atrophy | KG + DL |
| 45 | schizophrenia | KG + DL |
| 46 | inclusion body myositis | KG + DL |
| 47 | endogenous depression | KG + DL |
| 48 | neurohypophyseal diabetes insipidus | KG + DL |
| 49 | monogenic obesity | KG + DL |
| 50 | cluster headache syndrome | KG + DL |
(Showing top 50 of 58 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.